| Pharmaceutical active ingredients: |
| Chlorpheniramine MaleatePhenylpropanolamine Hydrochloride |
| Available forms, composition and doses of Contac Cold: |
| Capsules, Sustained Release; Oral; Chlorpheniramine Maleate 8 mg; Phenylpropanolamine Hydrochloride 75 mg |
| Contac Cold medical category: |
| Human:Cough and cold preparationsPropylamine derivativesSympathomimetic (adrenergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA51 - Phenylpropanolamine, combinationsR06AB54 - Chlorphenamine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Coldule V | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | Graham DM |
| Colvan | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | Pharma Dynamic |
| Condrin-LA | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | Shire |
| Conotab | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | Scort Pharmaceuticals; Sydenham Laboratories |
| Contac 12 Hour | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | GlaxoSmithKline |
| Contac Cold Extra Strength | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | GlaxoSmithKline |
| Contac Maximum Strength 12 Hour | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | GlaxoSmithKline |
| Contac Phenylpropanolamine | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | GlaxoSmithKline |
| Contac Rhume | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | GlaxoSmithKline |
| Contac Schnupfen | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | GlaxoSmithKline |